Investor confidence has been reinforced, thanks to the Italian luxury carmaker’s premium pricing model and long-term growth strategy.
The U.S. economy's resilience continues to defy expectations, with a robust fourth-quarter GDP growth of 3.3%, eclipsing forecasts of a slowdown. This surge in economic activity, amidst the Federal Reserve's...
Traditionally reliable, the 60/40 portfolio may no longer guarantee solid returns amid concerns about rising interest rates and rising bond yields.
Swiss pharmaceutical giant Novartis leaped 5.11% in the past week following news that its Kisqali breast-cancer treatment cut the probability of relapse.
The third quarter extended losses for most financial markets.